bluebird bio Inc. (BLUE)
NASDAQ: BLUE
· Real-Time Price · USD
4.97
0.00 (0.00%)
At close: May 30, 2025, 3:59 PM
bluebird bio Revenue
bluebird bio reported an annual revenue of $83.81M, reflecting a 184.12% growth. For the quarter ending March 31, 2025, bluebird bio generated $38.71M in revenue.
Revenue (ttm)
83.81M
Revenue Growth
184.12%
Price / Sales Ratio
0.96
Revenue / Employee
337.93K
Employees
248
Market Cap
48.67M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 83.81M | +184.12% |
| Dec 31, 2023 | 29.5M | +720.04% |
| Dec 31, 2022 | 3.6M | -1.77% |
| Dec 31, 2021 | 3.66M | -98.54% |
| Dec 31, 2020 | 250.73M | +461.25% |
| Dec 31, 2019 | 44.67M | -18.15% |
| Dec 31, 2018 | 54.58M | +54.06% |
| Dec 31, 2017 | 35.43M | +475.58% |
| Dec 31, 2016 | 6.16M | -56.28% |
| Dec 31, 2015 | 14.08M | -44.62% |
| Dec 31, 2014 | 25.42M | +25.97% |
| Dec 31, 2013 | 20.18M | +5835.59% |
| Dec 31, 2012 | 340K | -61.45% |
| Dec 31, 2011 | 882K | n/a |